Insider · CIK 0001421882

Durrant Cameron

Reports to the SEC for 5 companies · CALIFON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001421882

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-07-27	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+809K sh	—	—	808,906
2022-03-02	HUMANIGEN, INCP Purchase	Director, Chief Executive Officer	PPurchase	+40K sh	$2.34	+$93.6K	70,000
2022-01-12	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+84.4K sh	—	—	84,385
2021-12-31	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+76K sh	—	—	76,000
2021-11-23	HUMANIGEN, INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−17.7K sh	$4.53	−$80K	0
2021-09-30	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+17.7K sh	—	—	17,660
2021-06-14	HUMANIGEN, INCS Sale	Director, Chief Executive Officer	SSale	−26.4K sh	$20.60	−$545K	85,000
2021-06-14	HUMANIGEN, INCS Sale	Director, Chief Executive Officer	SSale	−5,094 sh	$21.14	−$108K	79,906
2021-06-14	HUMANIGEN, INCS Sale	Director, Chief Executive Officer	SSale	−49.9K sh	$20.61	−$1.03M	30,000
2021-03-12	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+653K sh	—	—	652,640
2021-03-01	HUMANIGEN, INCG Gift	Director, Chief Executive Officer	GGift	−111K sh	—	—	0
2021-03-01	HUMANIGEN, INCG Gift	Director, Chief Executive Officer	GGift	+111K sh	—	—	111,441
2020-10-05	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+82.6K sh	—	—	82,622
2020-05-20	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	$0.86	+$215K	250,000
2020-01-28	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+318K sh	$0.40	+$127K	318,103
2019-06-04	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+8,000 sh	$1.25	+$10K	557,207
2019-05-31	HUMANIGEN, INCJ Other	Director, Chief Executive Officer	JOther	+236K sh	—	—	549,207
2019-04-23	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+75K sh	$0.67	+$49.9K	313,583
2019-04-23	HUMANIGEN, INCEmployee Stock Option Exercise (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−75K sh	—	—	8,359,771
2019-03-08	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+75K sh	$0.67	+$49.9K	238,583
2019-03-08	HUMANIGEN, INCEmployee Stock Option Exercise (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−75K sh	—	—	8,434,771
2019-01-25	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+143K sh	—	—	142,857
2018-12-14	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+4,000 sh	$0.82	+$3,264	163,583
2018-12-12	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+2,000 sh	$0.82	+$1,643.8	159,583
2018-12-11	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+2,500 sh	$0.76	+$1,892.5	157,583
2018-12-10	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+2,500 sh	$0.75	+$1,875	155,083
2018-12-07	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+7,000 sh	$0.74	+$5,173	152,583
2018-12-06	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+10K sh	$0.73	+$7,320	145,583
2018-03-09	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+7.47M sh	—	—	8,509,771
2017-01-25	IMMUNE PHARMACEUTICALS INCStock OptionA Award	Director	AAward	+500K sh	—	—	690,000
2016-09-13	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.04M sh	—	—	1,043,022
2016-06-30	HUMANIGEN, INCA Award	Director, Chief Executive Officer	AAward	+136K sh	—	—	135,583
2016-06-01	IMMUNE PHARMACEUTICALS INCStock OptionA Award	Director	AAward	+50K sh	—	—	190,000
2016-01-29	IMMUNE PHARMACEUTICALS INCStock OptionA Award	Director	AAward	+40K sh	—	—	40,000
2015-01-08	IMMUNE PHARMACEUTICALS INCStock OptionA Award	Director	AAward	+50K sh	—	—	50,000
2014-11-26	IMMUNE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+4,000 sh	$2.50	+$10K	4,000
2014-11-26	IMMUNE PHARMACEUTICALS INCWarrantP Purchase	Director	PPurchase	+1,000 sh	—	—	1,000
2014-07-10	IMMUNE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2013-04-05	THERTHERALINK TECHNOLOGIES, INC.P Purchase	Director, President, CEO, CFO, Treasurer, 10% Owner	PPurchase	−4.25M sh	$0.01	−$51K	0
2013-03-11	HI TECH PHARMACAL CO INCStock Option (Right to Buy)A Award	President, CEO of ECR Pharm.	AAward	+50K sh	—	—	50,000
2010-06-29	AVXLANAVEX LIFE SCIENCES CORP. · stock optionsA Award	Director, Executive Chairman	AAward	+50K sh	—	—	1,000,000
2009-06-18	AVXLANAVEX LIFE SCIENCES CORP.J Other	Director, Executive Chairman	JOther	−75K sh	—	—	0
2009-05-13	AVXLANAVEX LIFE SCIENCES CORP. · stock optionsA Award	Director, Executive Chairman	AAward	+400K sh	—	—	950,000
2008-05-20	AVXLANAVEX LIFE SCIENCES CORP. · stock optionsA Award	Director, Executive Chairman	AAward	+400K sh	—	—	550,000

Recent filings

Accepted (ET)
Jul 294
Durrant Cameron0001214659-22-009383
SEC(opens sec.gov)
Mar 44
Durrant Cameron0001214659-22-003623
SEC(opens sec.gov)
Jan 144
Durrant Cameron0001214659-22-000739
SEC(opens sec.gov)
Jan 44
Durrant Cameron0001214659-22-000264
SEC(opens sec.gov)
Nov 264
Durrant Cameron0001214659-21-012328
SEC(opens sec.gov)
Oct 44
Durrant Cameron0001214659-21-010215
SEC(opens sec.gov)
Jun 164
Durrant Cameron0001214659-21-006640
SEC(opens sec.gov)
Mar 154
Durrant Cameron0001214659-21-003157
SEC(opens sec.gov)
Oct 74
Durrant Cameron0001214659-20-008470
SEC(opens sec.gov)
May 214
Durrant Cameron0001214659-20-004918
SEC(opens sec.gov)
Jan 294
Durrant Cameron0001214659-20-000663
SEC(opens sec.gov)
Jun 54
Durrant Cameron0001214659-19-004076
SEC(opens sec.gov)
May 314
Durrant Cameron0001214659-19-003929
SEC(opens sec.gov)
Apr 254
Durrant Cameron0001214659-19-002905
SEC(opens sec.gov)
Mar 114
Durrant Cameron0001214659-19-002039
SEC(opens sec.gov)

Companies

Address

90, FAIRMOUNT ROAD WEST

CALIFON, NJ, 07830-3330